A Study of the Role of Antiplatelet Therapy in the Prevention of Thrombosis in Patients with Calr-Mutated Low Risk Essential ThrombocythemiaAlberto Álvarez‐Larrán, Carlos Besses, Björn Andréasson et al.|Blood|2015Cited by 2
Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted GraftsYan Beauverd, Yves Chalandon, Sarah Morin et al.|Transplantation and Cellular Therapy|2020Cited by 1
Impact of Different T Cell Depletion Protocols on Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell TransplantationAmandine Pradier, Yves Chalandon, Adrien Petitpas et al.|Blood|2020Cited by 1
The AML EBMT Cytogenetic Risk Score for Acute Myeloid Leukaemia (AML) Is Prognostic for Outcomes of Allogeneic Stem Cell (HSCT)Yan Beauverd, Yves Chalandon, Sarah Morin et al.|Blood|2020Cited by 0